[1]曹晓琳,熊 琴,苏科文.经鼻高流量湿化氧疗治疗重症肺炎疗效及对患者血气指标和插管率的影响[J].陕西医学杂志,2023,52(7):871-874.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.022]
　CAO Xiaolin,XIONG Qin,SU Kewen.Efficacy of high-flow nasal cannula oxygen therapy in treatment of severe pneumonia and its influence on blood gas indexes and intubation rate[J].,2023,52(7):871-874.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.022]
点击复制

经鼻高流量湿化氧疗治疗重症肺炎疗效及对患者血气指标和插管率的影响
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年7期
页码:
871-874
栏目:
临床研究
出版日期:
2023-07-05

文章信息/Info

Title:
Efficacy of high-flow nasal cannula oxygen therapy in treatment of severe pneumonia and its influence on blood gas indexes and intubation rate
作者:
曹晓琳; 熊 琴; 苏科文
(四川大学华西医院呼吸与危重症医学科,四川 成都 610041)
Author(s):
CAO Xiaolin; XIONG Qin; SU Kewen
(Department of Respiratory and Critical Care Medicine,West China Hospital,Sichuan University,Chengdu 610041,China)
关键词:
重症肺炎;  经鼻高流量湿化氧疗;  疗效;  血气分析指标;  气管插管;  痰液黏稠度;  并发症
Keywords:
Severe pneumonia;  High-flow nasal cannula oxygen therapy;  Efficacy;  Blood gas index;  Tracheal intubation;  Sputum viscosity;  Complication
分类号:
R 563.1
DOI:
DOI:10.3969/j.issn.1000-7377.2023.07.022
文献标志码:
A
摘要:
目的:探究经鼻高流量湿化氧疗(HFNC)治疗重症肺炎(SP)的疗效及对血气分析指标和插管率的影响。方法:选取82例SP患者作为研究对象,采用随机数字表法分为两组,各41例。两组均给予对症治疗,对照组同时采用无创机械通气治疗,试验组采用HFNC治疗,比较两组患者疗效、治疗前后血气分析指标、插管率、痰液黏稠度以及并发症发生情况。结果:两组治疗有效率比较,试验组87.80%(36/41)高于对照组68.29%(28/41)(P<0.05); 两组治疗后血气分析指标:氢离子浓度(pH)值、氧合指数(OI)比较差异无统计学意义(均P>0.05),试验组二氧化碳分压(PaCO2)、呼吸频率(RR)低于对照组,氧分压(PaO2)高于对照组(均P<0.05); 试验组插管率4.88%与对照组的9.76%比较差异无统计学意义(P=0.675); 两组治疗后痰液黏度Ⅱ级人数增加,Ⅲ、Ⅳ级减少,比较差异具有统计学意义(均P<0.05); 两组并发症发生率比较,试验组4.88%(2/41)低于对照组9.76%(4/41),但两者比较差异无统计学意义(P>0.05)。结论:对SP患者采取HFNC治疗可改善疗效及血气分析指标且不增加插管率、改善痰液黏度、安全性高。
Abstract:
Objective:To investigate the efficacy of high-flow nasal cannula oxygen therapy(HFNC)in the treatment of severe pneumonia(SP),and its influence on blood gas indexes and intubation rate.Methods:A total of 82 patients with SP were randomly divided into two groups,with 41 cases in each group.Both groups were given symptomatic treatment.On this basis,the control group underwent non-invasive mechanical ventilation,while the experimental group underwent HFNC.The efficacy,blood gas indexes and sputum before and after treatment,viscosity intubation rate,and complications were compared between the two groups.Results:The treatment response rate in the experimental group was higher than that in the control group [87.80%(36/41)vs.68.29%(28/41),P<0.05].After treatment,there were no significant differences in pH and OI between the two groups(all P>0.05); the PaCO2 and RR in the experimental group were lower than those in the control group,and PaO2 was higher than that in the control group(all P<0.05).The intubation rates in the experimental group and the control group were 4.88% and 9.76%,without statistically significant difference between groups(P=0.675).After treatment,patients with grade Ⅱ sputum viscosity increased,and patients with grade Ⅲ and Ⅳ sputum viscosity decreased in the two groups(all P<0.05).The incidence rate of complications in the experimental group was lower than that in the control group [4.88%(2/41)vs.9.76%(4/41),P>0.05].Conclusion:HFNC can improve the efficacy and blood gas indexes in the treatment of SP patients,and it does not increase the intubation rate and improves sputum viscosity,with high safety.

参考文献/References:

[1] 魏永梅,马俊彦,李 阳,等.纤维支气管镜肺泡灌洗治疗支气管扩张合并肺部感染临床疗效Meta分析[J].陕西医学杂志,2021,50(7):893-898.
[2] 陈 韵,张星星,高志凌,等.清金化痰汤加减辅助抗生素治疗老年重症肺炎疗效及对患者炎症反应递质的影响[J].陕西中医,2022,43(5):580-583.
[3] 李风峰,康占旺,曾 璐,等.左卡尼汀辅助治疗重症肺炎伴发心力衰竭对患儿炎症细胞及T淋巴细胞水平的影响[J].陕西医学杂志,2020,49(1):56-59.
[4] Plotnikow GA,Villalba D,Gogniat E,et al.Performance of different active humidification systems in high-flow oxygen therapy[J].Respir Care,2020,65(9):1250-1257.
[5] Delorme M,Bouchard PA,Simard S,et al.Hygrometric performances of different high-flow nasal cannula devices:Bench evaluation and clinical tolerance[J].Respir Care,2021,66(11):1720-1728.
[6] 中华医学会呼吸病学分会.中国成人社区获得性肺炎诊断和治疗指南(2016年版)[J].中华结核和呼吸杂志,2016,39(4):253-279.
[7] 中国医师协会急诊医师分会.中国急诊重症肺炎临床实践专家共识[J].中国急救医学,2016,36(2):97-107.
[8] 叶 青,田瑞雪,可爱华,等.经鼻高流量氧疗治疗老年重症肺炎的临床疗效和安全性研究[J].中国医学装备,2020,17(2):95-98.
[9] 张俊丽,卜金龙,孙文武,等.机械通气时不同黏稠度模拟痰液流变学的实验研究[J].护理学杂志,2018,33(6):54-56.
[10] 张惠民,杜旭升,范亚莉,等.重症肺炎120例多重耐药菌感染情况及影响因素分析[J].陕西医学杂志,2022,51(7):835-838,842.
[11] Jouan Y,Si-Tahar M,Paget C.Severe pneumonia and acute respiratory distress syndrome:Implication of unconventional T cells[J].Rev Mal Respir,2019,36(4):451-454.
[12] Rachina S,Zakharenkov I,Dekhnich N,et al.Aetiology of severe community-acquired pneumonia and antimicrobial susceptibility of Streptococcus pneumoniae in adults in Russia[J].J Antimicrob Chemother,2021,76(5):1368-1370.
[13] 谢 波,高 颖.经鼻高流量湿化氧疗联合肺泡灌洗治疗重症肺炎合并呼吸衰竭患者疗效观察[J].陕西医学杂志,2023,52(1):49-52.
[14] 杨文林,倪红燕,王海峰.经鼻高流量氧疗序贯治疗慢性阻塞性肺疾病合并呼吸衰竭临床研究[J].陕西医学杂志,2020,49(10):1280-1282,1287.
[15] 徐文斌,赵海莲.高流量氧疗治疗轻中度呼吸衰竭疗效及安全性研究[J].陕西医学杂志,2020,49(3):296-299.
[16] Munsif M,Mc Donald C,Goh N,et al.Nasal high flow oxygen therapy during acute admissions or periods of worsening symptoms[J].Curr Opin Support Palliat Care,2021,15(4):205-213.
[17] 康 睿,刘慧霞.肺部感染控制窗序贯通气在慢性阻塞性肺疾病急性加重期合并呼吸衰竭治疗中的应用价值研究[J].陕西医学杂志,2022,51(3):342-346.
[18] 施 俊,仝 婕,张 炜,等.经鼻高流量湿化氧疗在重症肺炎患者呼吸道管理中的效果探讨[J].上海护理,2022,22(8):38-40.
[19] Guia M,Alpay N,Gerardo A,et al.High-flow nasal oxygen therapy in acute hypoxemic respiratory failure:Concise review on technology and initial methodology[J].Turk Thorac J,2021,22(6):494-500.
[20] 蒋亚林,赵 妍,张孝飞,等.经鼻高流量湿化氧疗对支气管镜肺泡灌洗术中低氧血症的防治效果观察[J].山东医药,2022,62(30):47-49.
[21] 潘 宸,朱涵菁,杨鹏飞,等.ICU气管插管拔管后病人应用经鼻高流量湿化氧疗的最佳证据总结[J].护理研究,2022,36(3):421-427.

相似文献/References:

[1]李江涛,华爱玲,赵竹莉.呼吸机肺保护性通气联合人免疫球蛋白治疗〖JZ〗重症肺炎合并呼吸衰竭疗效研究*[J].陕西医学杂志,2019,(10):1302.
　LI Jiangtao,HUA Ailing,ZHAO Zhuli..Effect of ventilatorlung protective ventilation combined with 〖JZ〗human immunoglobulin on severe pneumonia with respiratory failure[J].,2019,(7):1302.
[2]彭林强,薛 满,马春利,等.头孢噻肟钠联合酚妥拉明治疗重症肺炎疗效及对患儿肺功能、免疫功能、炎症因子水平的影响*[J].陕西医学杂志,2019,(11):1556.
[3]李风峰,康占旺,曾 璐,等.左卡尼汀辅助治疗重症肺炎伴发心力衰竭对患儿炎症细胞及T淋巴细胞水平的影响*[J].陕西医学杂志,2020,49(1):56.
[4]张惠民,杜旭升,范亚莉,等.重症肺炎120例多重耐药菌感染情况及影响因素分析[J].陕西医学杂志,2022,51(7):835.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.016]
　ZHANG Huimin,DU Xusheng,FAN Yali,et al.Situation and influencing factors of multidrug-resistant organism infection in 120 patients with severe pneumonia[J].,2022,51(7):835.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.016]
[5]谢 波,高 颖.经鼻高流量湿化氧疗联合肺泡灌洗治疗重症肺炎合并呼吸衰竭患者疗效观察[J].陕西医学杂志,2023,52(1):49.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.011]
　XIE Bo,GAO Ying.Efficacy of nasal high-flow humidified oxygen therapy combined with bronchoalveolar lavage in treatment of severe pneumonia with respiratory failure[J].,2023,52(7):49.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.011]
[6]巩 娟,张 栋.血清长链非编码RNA 小核仁RNA宿主基因16和miR-147a在重症肺炎患者血清中的表达及临床意义[J].陕西医学杂志,2023,52(1):75.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.017]
　GONG Juan,ZHANG Dong.Expression and clinical significance of serum lncRNA SNHG16 and miR-147a in patients with severe pneumonia[J].,2023,52(7):75.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.017]
[7]吕玉颖,曹志新,马玉平.无创通气间歇期经鼻高流量湿化氧疗治疗慢性阻塞性肺疾病急性加重临床效果及对患者气管插管率、血气指标的影响[J].陕西医学杂志,2024,(7):922.[doi:DOI:10.3969/j.issn.1000-7377.2024.07.012]
　LYU Yuying,CAO Zhixin,MA Yuping.Therapeutic effect of high-flow nasal cannula oxygen therapy during intermittent period of noninvasive ventilation on AECOPD and its influence on tracheal intubation time and blood gas indicators[J].,2024,(7):922.[doi:DOI:10.3969/j.issn.1000-7377.2024.07.012]
[8]乔秀娟,李姿男,鲁张波,等.老年重症肺炎患者血清叉头状转录因子1、磷脂酶A2、纤维蛋白降解产物水平变化及与短期预后的关系[J].陕西医学杂志,2025,54(4):507.[doi:DOI:10.3969/j.issn.1000-7377.2025.04.014]
[9]吴秀娟,韩 娜,菅辉玲,等.血清可溶性髓系细胞触发受体1、磷脂酶A2及国家早期预警评分对重症肺炎所致呼吸窘迫综合征患者预后的评估价值[J].陕西医学杂志,2025,54(4):550.[doi:DOI:10.3969/j.issn.1000-7377.2025.04.023]
　WU Xiujuan,HAN Na,KAN Huiling,et al.Prognostic value of serum soluble myeloid cell trigger receptor 1,phospholipase A2 and NEWS score in ARDS patients with severe pneumonia[J].,2025,54(7):550.[doi:DOI:10.3969/j.issn.1000-7377.2025.04.023]

备注/Memo

备注/Memo:
基金项目:四川省卫生健康委员会科研课题(19PJ249)
更新日期/Last Update: 2023-07-05